These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 23884225)
1. Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes. Millner LM; Linder MW; Valdes R Ann Clin Lab Sci; 2013; 43(3):295-304. PubMed ID: 23884225 [TBL] [Abstract][Full Text] [Related]
2. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410 [TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells: a multifunctional biomarker. Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278 [TBL] [Abstract][Full Text] [Related]
4. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype. Wang H; Wu X Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biological significance of circulating tumor cells in cancer. Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533 [TBL] [Abstract][Full Text] [Related]
6. Seeding metastases: The role and clinical utility of circulating tumour cells. Patel DA; Blay J Tumour Biol; 2021; 43(1):285-306. PubMed ID: 34690152 [TBL] [Abstract][Full Text] [Related]
8. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
9. Classification of circulating tumor cells by epithelial-mesenchymal transition markers. Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application. Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872 [TBL] [Abstract][Full Text] [Related]
11. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives. Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440 [TBL] [Abstract][Full Text] [Related]
12. Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs). Myung JH; Park SJ; Wang AZ; Hong S Adv Drug Deliv Rev; 2018 Feb; 125():36-47. PubMed ID: 29247765 [TBL] [Abstract][Full Text] [Related]
13. Analogous detection of circulating tumor cells using the AccuCyte van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777 [TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition. Lowes LE; Allan AL Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372 [TBL] [Abstract][Full Text] [Related]
17. Benchtop technologies for circulating tumor cells separation based on biophysical properties. Low WS; Wan Abas WA Biomed Res Int; 2015; 2015():239362. PubMed ID: 25977918 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810 [TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Lianidou ES; Markou A Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells. Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]